Cargando…
In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function
MicroRNA 34a (miR-34a) is elevated in the heart in a setting of cardiac stress or pathology, and we previously reported that inhibition of miR-34a in vivo provided protection in a setting of pressure overload-induced pathological cardiac hypertrophy and dilated cardiomyopathy. Prior work had also sh...
Autores principales: | Bernardo, Bianca C., Yildiz, Gunes S., Kiriazis, Helen, Harmawan, Claudia A., Tai, Celeste M. K., Ritchie, Rebecca H., McMullen, Julie R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563608/ https://www.ncbi.nlm.nih.gov/pubmed/36231079 http://dx.doi.org/10.3390/cells11193117 |
Ejemplares similares
-
Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
por: Huynh, Karina, et al.
Publicado: (2010) -
Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges
por: Bernardo, Bianca C., et al.
Publicado: (2018) -
Silencing of miR-34a Attenuates Cardiac Dysfunction in a Setting of Moderate, but Not Severe, Hypertrophic Cardiomyopathy
por: Bernardo, Bianca C., et al.
Publicado: (2014) -
Echocardiographic diastolic function assessment is of modest utility in patients with persistent and longstanding persistent atrial fibrillation
por: Kohári, Mária, et al.
Publicado: (2015) -
Effects of Transendocardial CD34(+) Cell Transplantation on Diastolic Parameters in Patients with Nonischemic Dilated Cardiomyopathy
por: Bervar, Mojca, et al.
Publicado: (2017)